Creative Planning
RVMD icon

Creative Planning’s Revolution Medicines RVMD Stock Holding History

Creative Planning’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.8M Buy
49,392
+5,248
+12% +$530K ﹤0.01% 1229
2025
Q4 		$3.52M Buy
44,144
+5,206
+13% +$341K ﹤0.01% 1257
2025
Q3 		$1.82M Sell
38,938
-26,776
-41% -$1.05M ﹤0.01% 1623
2025
Q2 		$2.42M Buy
65,714
+20,616
+46% +$792K ﹤0.01% 1186
2025
Q1 		$1.59M Buy
45,098
+1,713
+4% +$69.5K ﹤0.01% 1357
2024
Q4 		$1.9M Buy
43,385
+5,517
+15% +$278K ﹤0.01% 1158
2024
Q3 		$1.72M Buy
37,868
+10,839
+40% +$472K ﹤0.01% 1165
2024
Q2 		$1.05M Buy
27,029
+10,667
+65% +$399K ﹤0.01% 1371
2024
Q1 		$527K Buy
+16,362
New +$485K ﹤0.01% 1818

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Creative Planning's RVMD Position: Q1 2026 in Review

Creative Planning increased its Revolution Medicines (RVMD) stake by 12% in Q1 2026, buying an estimated $530K and bringing the position to 49,392 shares worth $4.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Creative Planning first reported a position in RVMD in Q1 2024 and has held it in 9 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Creative Planning held 49,392 shares of Revolution Medicines worth $4.8M as of Q1 2026.
  • Creative Planning bought 5,248 Revolution Medicines shares in Q1 2026, an estimated $530K.
  • Revolution Medicines made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1229 holding.
  • Creative Planning first reported a position in Revolution Medicines in Q1 2024 and has held it in 9 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.